This study utilized immunohistochemistry (IHC) to assess the expression of the IGF2BP3 protein in 299 cases of breast cancer tissues, with the aim of investigating the clinical and diagnostic significance of IGF2BP3 in breast cancer. This evidence concerns the gene IGF2BP3 and breast cancer.